SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: ESPR

No earlier versions found for this Subject.


Return to ESPR
 
This unique new biotech company has an original and promising approach to prevent or cure cardiovascular and cerebrovascular disease. These diseases directly account for 2/3 of all human deaths and thus are far more important than cancer and all other diseases combined. ESPR's approach, in certain ways, resemble those of other biotech companies that target angiogenesis as a method to cure cancer. Let's hope they all succeed.

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News